Neratinib

Name: Neratinib | 698387-09-6
Brand: US-CATO
SKU: S57C4X-1134_10_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57C4X-1134_10_MG

Vendor: US-CATO

Product Information

Product Name

Neratinib

Brand Name

US-CATO

Product Number

C4X-1134

CAS

698387-09-6

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

9915743

IUPAC Name

(E)-N-4-3-chloro-4-(pyridin-2-ylmethoxy)anilino-3-cyano-7-ethoxyquinolin-6-yl-4-(dimethylamino)but-2-enamide

InChI Key

JWNPDZNEKVCWMY-VQHVLOKHSA-N

SMILES

CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C

References Data Source From Pubchem

Breast cancer: taxonomy, distribution analysis, risk factors, predictive biomarkers, and modern treatment method

Publication Name: Apoptosis : an international journal on programmed cell death

Publication Date: 2026-02-20

DOI: 10.1007/s10495-026-02281-7

HER2 heterogeneity between primary cancers and brain metastases: a retrospective analysis of 185 matched pairs across multiple cancer types

Publication Name: Journal of Neuro-Oncology

Publication Date: 2026-02-20

DOI: 10.1007/s11060-026-05476-9

The evolving landscape of bench-to-bedside translation in the era of neoadjuvant platforms: perspectives and opportunities

Publication Name: Holistic Integrative Oncology

Publication Date: 2026-02-14

DOI: 10.1007/s44178-025-00219-8

Atrial fibrillation associated with tyrosine kinase inhibitors: A case–control study of real-world pharmacovigilance data

Publication Name: Naunyn-Schmiedeberg's Archives of Pharmacology

Publication Date: 2026-02-10

DOI: 10.1007/s00210-026-05078-2

Computational exploration of novel indanone-pyrazole fused schiff base scaffolds as potential EGFR inhibitors for anticancer therapy

Publication Name: Discover Chemistry

Publication Date: 2026-02-10

DOI: 10.1007/s44371-026-00503-0

Neratinib

Product Information

General Information

References Data Source From Pubchem

Breast cancer: taxonomy, distribution analysis, risk factors, predictive biomarkers, and modern treatment method

HER2 heterogeneity between primary cancers and brain metastases: a retrospective analysis of 185 matched pairs across multiple cancer types

The evolving landscape of bench-to-bedside translation in the era of neoadjuvant platforms: perspectives and opportunities

Atrial fibrillation associated with tyrosine kinase inhibitors: A case–control study of real-world pharmacovigilance data

Computational exploration of novel indanone-pyrazole fused schiff base scaffolds as potential EGFR inhibitors for anticancer therapy

Neratinib

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

About Us

Popular Searches

Contact

#title#

Features
Availability:
Price
Options
Actions

Neratinib

Product Information

General Information

References Data Source From Pubchem

Breast cancer: taxonomy, distribution analysis, risk factors, predictive biomarkers, and modern treatment method

HER2 heterogeneity between primary cancers and brain metastases: a retrospective analysis of 185 matched pairs across multiple cancer types

The evolving landscape of bench-to-bedside translation in the era of neoadjuvant platforms: perspectives and opportunities

Atrial fibrillation associated with tyrosine kinase inhibitors: A case–control study of real-world pharmacovigilance data

Computational exploration of novel indanone-pyrazole fused schiff base scaffolds as potential EGFR inhibitors for anticancer therapy

Neratinib

Related Product

Mycophenolate Mofetil EP Impurity H

Mycophenolate Mofetil

Flurbiprofen Impurity 21 (Mixture of Diastereomers)

Docetaxel Impurity 40

H-Met-Glu-OH

Fluticasone Impurity 106

Efavirenz Related Compound C

Cholecalciferol EP Impurity A

#title#

Login

Register